Literature DB >> 14971690

The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas.

Brian Greenwood1.   

Abstract

Anti-malarial drugs have been used in various ways to prevent malaria in the resident populations of endemic areas for nearly 100 years. The primary aim of most early studies was to interrupt transmission. This was rarely achieved, but administration of anti-malarial drugs either through medication of salt or by mass administration frequently led to a marked reduction in the prevalence of malaria infection and in the incidence of clinical attacks. Chemoprophylaxis is highly effective in reducing mortality and morbidity from malaria in young children and pregnant women living in endemic areas, but is difficult to sustain and, in some studies, has impaired the development of naturally acquired immunity. Intermittent preventive treatment, in which full therapeutic doses of a drug are given at defined intervals, has the potential to provide some of the benefits of sustained chemoprophylaxis in pregnant women and young children without some of its drawbacks and is a promising new approach to malaria control.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14971690

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  38 in total

1.  The implementation of malaria intermittent preventive trialtreatment with sulphadoxine-pyrimethamine in infants reduced all-cause mortality in the district of Kolokani, Mali: results from a cluster randomized control.

Authors:  Alassane Dicko; Moussa Konare; Djibril Traore; Jean Testa; Roger Salamon; Ogobara Doumbo; Christophe Rogier
Journal:  Malar J       Date:  2012-03-16       Impact factor: 2.979

2.  Plasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virus.

Authors:  Samuel Malamba; Taylor Sandison; John Lule; Arthur Reingold; Jordan Walker; Grant Dorsey; Jonathan Mermin
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

3.  Scaling up of intermittent preventive treatment of malaria in pregnancy using sulphadoxine-pyrimethamine: prospects and challenges.

Authors:  Wellington Aghoghovwia Oyibo; Chimere Obiora Agomo
Journal:  Matern Child Health J       Date:  2011-05

Review 4.  Mass drug administration for malaria.

Authors:  Eugenie Poirot; Jacek Skarbinski; David Sinclair; S Patrick Kachur; Laurence Slutsker; Jimee Hwang
Journal:  Cochrane Database Syst Rev       Date:  2013-12-09

5.  Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial.

Authors:  Mark C Steinhoff; Saad B Omer; Eliza Roy; Shams El Arifeen; Rubhana Raqib; Caitlin Dodd; Robert F Breiman; K Zaman
Journal:  CMAJ       Date:  2012-02-21       Impact factor: 8.262

6.  Implementing Intermittent Preventive Treatment for Malaria in Pregnancy: Review of Prospects, Achievements, Challenges and Agenda for Research.

Authors:  Godfrey Martin Mubyazi; Pascal Magnussen; Catherine Goodman; Ib Christian Bygbjerg; Andrew Yona Kitua; Oystein Evjen Olsen; Jens Byskov; Kristian Schultz Hansen; Paul Bloch
Journal:  Open Trop Med J       Date:  2008

Review 7.  Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control.

Authors:  Simon Brooker; Willis Akhwale; Rachel Pullan; Benson Estambale; Siân E Clarke; Robert W Snow; Peter J Hotez
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

8.  Diagnosing infection levels of four human malaria parasite species by a polymerase chain reaction/ligase detection reaction fluorescent microsphere-based assay.

Authors:  David T McNamara; Laurin J Kasehagen; Brian T Grimberg; Jennifer Cole-Tobian; William E Collins; Peter A Zimmerman
Journal:  Am J Trop Med Hyg       Date:  2006-03       Impact factor: 2.345

9.  The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives.

Authors:  Ricardo Aguas; José M L Lourenço; M Gabriela M Gomes; Lisa J White
Journal:  PLoS One       Date:  2009-08-13       Impact factor: 3.240

10.  Implications of malaria on iron deficiency control strategies.

Authors:  Natasha Spottiswoode; Michal Fried; Hal Drakesmith; Patrick E Duffy
Journal:  Adv Nutr       Date:  2012-07-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.